Oxytocin

Oxytocin is a hypothalamic nonapeptide hormone used off-label to manage anxiety, stress, and mood, as well as to support sexual function and social bonding. Users typically run daily protocols with doses ranging from 20 µg to 18 mg, though 10 mg is the most common reported amount. While the substance is well-known in clinical settings for labor induction and postpartum hemorrhage, the broader evidence base for its exploratory uses remains thin, with many potential applications lacking published trial results. Readers should note that the current body of evidence for these off-label indications is significantly less robust than the community discourse suggests.

Half-life~4 min

Data last updated

ClinicalResearchDepthClinicalResearchEfficacyClinicalResearchSideEffectsAnecdotalEfficacyAnecdotalSideEffectsPrice3.75.01.43.22.93.0

Research Evidence

Evidence shape

Oxytocin carries high-tier clinical evidence, primarily established through its standard use in labor induction and the management of postpartum hemorrhage. While the literature includes over 200 registered trials and 32 blinded studies across 133 distinct indications, the vast majority of these applications remain exploratory or limited to single-trial investigations. This broad mapping indicates that while the peptide is well-validated for specific obstetric applications, most other proposed uses in psychiatric or cognitive domains lack the robust, multi-trial confirmation required to move beyond preliminary research.

Depthhow much
241 registered trials
139 completed · 47 with posted results · 29 recruiting / active · combined n=4636
Breadthhow many areas
130 indications mapped
17 with results · 98 thin / exploratory · 1 animal-only · 96 single-trial long-tail
Qualityhow rigorous
Highest tier: Phase 3
36 blinded with results · 87 distinct sponsors · AE rows aggregated from 32 trials · 31 linked publications on registered trials
Breadth and depth253 rows captured
Human
direct clinical signal
244
Animal
translational support
9
In vitro
mechanistic support
0
HighMediumLow

Anecdotal efficacy

1
US
102 mg
$59.99
$0.588/mg
2
GB
10 mg
$20.13
$2.01/mg
3
--
50 mg×10
$114.00
$2.28/mg
4
--
20 mg
$48.00
$2.4/mg
5
--
10 mg
$29.99
$3/mg
6
GB
10 mg
$33.42
$3.34/mg

price offers can be sorted by column

1-6 of 132

Oxytocin dosing & protocol

How Oxytocin is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.

Research trials
Published clinical-trial protocols · n = 152
Typical dose
13.4 mg400 µg – 40.3 mg
typical
0
10 mg
20 mg
30 mg
40 mg
50 mg
distribution of 7 reported doses · darker = more
Frequency
daily
Route
intranasal

In research trials, oxytocin was given intranasally at a typical dose of 13.4 mg daily, with individual doses ranging from 400 µg to 40.3 mg.

152 sources
Clinician practice
Doctor & published-protocol guidance
Typical dose
0
10 mg
20 mg
30 mg
40 mg
50 mg
no dose captured for this tier yet

No structured protocol details captured for this tier yet.

Anecdotal
Community-reported real-world use · n = 31
Typical dose
10 mg20 µg – 18 mg
typical
0
10 mg
20 mg
30 mg
40 mg
50 mg
distribution of 37 reported doses · darker = more
By reported cadence· tap a row to filter the chart
Frequency
mixed
Route
subQ

Among community reports, most users did not state a schedule; of those who did, daily dosing (5 reports) was most common, typically around 5 mg, while weekly use (4 reports) averaged about 1 mg. Doses overall spanned 20 mcg to 18 mg, and no cycling pattern was described.

31 sources

Regulatory safety notes

Contraindications
  • CONTRAINDICATIONS Oxytocin injection (synthetic) is contraindicated in any of the following conditions: Significant cephalopelvic disproportion; Unfavorable fetal positions or presentations which are undeliverable witho…
  • Patients with hypersensitivity to the drug; Induction or augmentation of labor in those cases where vaginal delivery is contraindicated, such as cord presentation or prolapse, total placenta previa, and vasa previa.
Drug interactions
  • Drug Interactions Severe hypertension has been reported when oxytocin was given three to four hours following prophylactic administration of a vasoconstrictor in conjunction with caudal block anesthesia. Cyclopropane anesthesia may modify oxytocin’s cardiovas…